NDC 53852-0010 Lung Remedy Phase 1

NDC Product Code 53852-0010

NDC CODE: 53852-0010

Proprietary Name: Lung Remedy Phase 1 What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.

NDC Code Structure

  • 53852 - Living Well Remedies, Llc

NDC 53852-0010-4

Package Description: 118 mL in 1 BOTTLE

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

NDC Product Information

Lung Remedy Phase 1 with NDC 53852-0010 is a product labeled by Living Well Remedies, Llc. The product's dosage form is and is administered via form.

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • WATER (UNII: 059QF0KO0R)
  • CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
  • POTASSIUM SORBATE (UNII: 1VPU26JZZ4)

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Living Well Remedies, Llc
Labeler Code: 53852
Start Marketing Date: 10-29-2012 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2018 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: I - INACTIVATED, the listing data was inactivated by the FDA. What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

* Please review the disclaimer below.

Lung Remedy Phase 1 Product Label Images

Lung Remedy Phase 1 Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Otc - Active Ingredient

Active Ingredients: Official HPUS: Carbo vegetabilis, Bromium, Lobelia inflata, Phosphorus, Silicea. Equal volumes of each ingredient in 10C, 30C, LM1 potency.

Inactive Ingredient

Inactive ingredients: Bio-Energetically enhanced pure water base, citric acid and potassium sorbate.

Indications & Usage

Indications: Can help relieve effects from smoking such as cough, congestion, hoarse voice, difficulty breathing, shortness of breath.

Warnings

Warnings: If symptoms persist/worsen or if pregnant/nursing consult your health care professional.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

Other Safety Information

Do not use if safety seal is broken or missing.

Dosage & Administration

Directions:Phase 1 should be completed before beginning Phase 2.Take one teaspoon daily, 30 minutes away from food or drink. Use a clean plastic teaspoon. One bottle lasts approximately one month. Continue to take until bottle is empty before beginning the next phase of Lung Remedy.Lung Remedy is a three phase system that includes 3 bottles, each a different formula designed to work together. For maximum benefits from the effects of smoking, we recommend you take the complete system. Once you finish the Phase 1 bottle, then you can begin Phase 2. When Phase 2 bottle is empty, begin Phase 3. For more information, please visit www.LungRemedy.com

Otc - Purpose

  • Indications: Can help relieve effects from smoking such as:coughcongestionhoarse voicedifficulty breathingshortness of breath

* Please review the disclaimer below.